In a recent article, the journal Forschung Frankfurt (issue 1/2024) focuses on the promising possibilities of treating cardiovascular diseases with non-coding RNA (ncRNA). This most common cause of death worldwide claims almost 18 million lives every year - there is an urgent need for innovative therapies.